Afasevikumab
Afasevikumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).
| Trade Name | Afasevikumab |
| Generic | Afasevikumab |
| Afasevikumab Other Names | Afasevikumab, MCAF5352A |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Afasevikumab
